Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Lateral flow immunoassays, also called immunochromatography strips, are straightforward devices used to detect the absence or presence of a target analyte. Target analytes range from pathogens to ...
Point-of-care diagnostics similar to home COVID-19 tests were able to detect microbial keratitis (MK) caused by Aspergillus fungus with good accuracy, according to a prospective study. An ...
Researchers in ACS’ Analytical Chemistry report improved lateral flow assays for at-home screening of common pet diseases.
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
Hosted on MSN
How one company is disrupting PoC testing
The point-of-care (PoC) market continues to gain traction as it is expected to reach a market valuation of US$77.8 billion by 2028 and growing at a compound annual growth rate of 9.4 per cent. PoC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results